NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
18.49
-0.06 (-0.32%)
Apr 25, 2025, 4:00 PM EDT - Market closed
NovoCure Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for NovoCure stock have an average target of 32.83, with a low estimate of 27 and a high estimate of 40. The average target predicts an increase of 77.56% from the current stock price of 18.49.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for NovoCure stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Hold | 2 | 1 | 1 | 1 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $42 → $34 | Buy | Maintains | $42 → $34 | +83.88% | Apr 23, 2025 |
| Wedbush | Wedbush | Hold Maintains $29 → $27 | Hold | Maintains | $29 → $27 | +46.02% | Apr 16, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $29 → $28 | Hold | Maintains | $29 → $28 | +51.43% | Apr 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +105.52% | Jan 14, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $28 → $42 | Buy | Maintains | $28 → $42 | +127.15% | Dec 13, 2024 |
Financial Forecast
Revenue This Year
622.79M
from 605.22M
Increased by 2.90%
Revenue Next Year
687.97M
from 622.79M
Increased by 10.47%
EPS This Year
-2.02
from -1.56
EPS Next Year
-2.05
from -2.02
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 646.4M | 736.8M | 971.3M | ||
| Avg | 622.8M | 688.0M | 808.0M | ||
| Low | 593.9M | 636.0M | 667.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.8% | 18.3% | 41.2% | ||
| Avg | 2.9% | 10.5% | 17.4% | ||
| Low | -1.9% | 2.1% | -3.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.62 | -1.53 | -0.92 | ||
| Avg | -2.02 | -2.05 | -1.50 | ||
| Low | -2.81 | -2.69 | -2.27 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.